Sample Quality Control for Molecular Diagnostics

Why Should You Attend:

Since the beginning of the PCR revolution in the 1980s, molecular diagnostics have proven to be a useful tool for the clinical laboratory. The ability to analyze a variety of samples for DNA and RNA content have proven to be useful for a large number of clinical conditions using a number of different technologies. However, each technology has its pitfalls with how to handle samples for optimal results. In addition, different technologies have different challenges as to what can inhibit optimal results, and each technology has a unique solution to these pitfalls.

This webinar explains a variety of issues and how to address them. Common issues such as collection methods, sample inhibition and sample volume will be address. Also, each unique technology, from standard PCR, to DNA fluorescent assays, from next generation sequencing to newer technologies such as point of care and digital PCR, will have their various sample challenges addressed. This webinar will give you the tools you need to deal with your laboratories challenges.

Areas Covered in the Webinar:

This webinar will help you learn how to deal with sample quality control for molecular diagnostics. The webinar will include the following critical information you will need:

• Universal sample requirements for molecular diagnostics
• Strategies to deal with common challenges
• Challenges unique to PCR assays
• Challenges unique to DNA fluorescent assays
• Challenges unique to NGS assays
• Challenges unique to newer molecular technologies

Who Will Benefit:

This will benefit a wide array of professionals such as:

• Quality control
• Assay Development
• Assay validation
• Research and Development
• Clinical Diagnostics

Todd Graham
Managing Partner, Delevan Street Biosciences

Todd Graham is a clinical laboratory scientist for a large hospital system in the New York Tri-State Area as well as a scientific consultant for Fortune 500 biotechnology firms, healthcare systems throughout the world and R1 Research Level Universities. During his time as a clinical laboratory scientist in his current role, he has improved sample workflow and improved laboratory quality and sample turnaround time while expanding laboratory services to vulnerable health populations in the New York area. He has also provided outreach to the local community by serving as a mentor to students training in clinical laboratory science, as well as the scientific community by serving as a technical resource for his peers in the laboratory.

Through his work as a consultant, he has worked to improve the spread of key technical information in a variety of mediums. Todd has written a number of market research reports used by Fortune 500 biotechnology firms in strategic planning, and led webinars on key quality issues that impact the biotechnology community. He has served R1 Research Level Universities by advising them on strategic technology transfer opportunities, and has been called upon as a key knowledge leader internationally for the biotechnology industry.

Follow us :